Farmantra thanks all the Panelists, Speakers and audience for making the discussion on ‘Early stage value creation’ a tremendous success.
30th November 2018
Panelists
- GuillemLaporta – Principal, Ysios Capital, Spain
- Esteban Pombo-Villar – CEO, Targimmune, Switzerland
- Christofer Adding – COO, Attgeno, Sweden
- Raúl Insa – CEO, SOM Biotech, Spain
Keynote Speakers :
- Jordi Naval, CEO of Biocat, Spain
- Edoardo Negroni, Partner, Aurora TT, Italy
Leave a Comments